Madeleine Crawford, PA
Physician Assistant · San Diego, CANPI 1770117335
Payments from drug & device makers
Across 73 payments — averaging $25.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$342
- Novo Nordisk$193
- Lilly USA, LLC$183
- Inspire Medical Systems, Inc.$181
- AbbVie$101
- Stryker$100
- plus $741 from 21 others
What the payments were for
- Food & beverage$1,841100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 8 | $342 |
| Novo Nordisk | 12 | $193 |
| Lilly USA, LLC | 8 | $183 |
| Inspire Medical Systems, Inc. | 4 | $181 |
| AbbVie | 4 | $101 |
| Stryker | 2 | $100 |
| Astellas Pharma US Inc | 3 | $73 |
| Sanofi-aventis U.S. LLC | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Seqirus USA Inc | 3 | $53 |
| Pfizer | 2 | $52 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| Alk-abello, Inc | 2 | $38 |
| Merck | 1 | $33 |
| Optinose US, Inc. | 2 | $30 |
| Biotronik NRO, Inc. | 1 | $29 |
| Microtransponder, Inc. | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Boehringer Ingelheim | 1 | $27 |
| Si-bone, Inc. | 1 | $25 |
| Hospira, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $24 |
| Amgen | 1 | $24 |
| Intersect ENT, Inc. | 2 | $24 |
| Exact Sciences | 1 | $23 |
| Halozyme Inc | 1 | $16 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$227
How this compares
$1,841 in reported general payments places this provider in the 80th percentile of 10,423 physician assistant providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 46 | $914 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $656 |
| Gabapentin | 30 | $377 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 20 | $317 |
| Pantoprazole Sodium | 16 | $296 |
| Ibuprofen | 17 | $293 |
| Omeprazole | 23 | $292 |
| Atorvastatin Calcium | 20 | $285 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $244 |
| Levothyroxine Sodium | 23 | $235 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $233 |
| Methylprednisolone | 15 | $129 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $125 |
| Losartan Potassium | 28 | $125 |
| Alprazolam | 18 | $105 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in San Diego
- Jeremy AdlerSan Diego$82K
- Anne DenslowSan Diego$43K
- Kathryn SmileySan Diego$33K
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.